Cargando…
Concise Review: Application of Chemically Modified mRNA in Cell Fate Conversion and Tissue Engineering
Chemically modified RNA (cmRNA) has potential as a safe and efficient tool for nucleic acid‐based therapies and regenerative medicine. Modifications in the chemistry of mRNA can enhance stability, reduce immunogenicity, and thus facilitate mRNA‐based nucleic acid therapy, which eliminates risk of in...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6646692/ https://www.ncbi.nlm.nih.gov/pubmed/30891922 http://dx.doi.org/10.1002/sctm.18-0259 |
_version_ | 1783437592691212288 |
---|---|
author | Badieyan, Zohreh Sadat Evans, Todd |
author_facet | Badieyan, Zohreh Sadat Evans, Todd |
author_sort | Badieyan, Zohreh Sadat |
collection | PubMed |
description | Chemically modified RNA (cmRNA) has potential as a safe and efficient tool for nucleic acid‐based therapies and regenerative medicine. Modifications in the chemistry of mRNA can enhance stability, reduce immunogenicity, and thus facilitate mRNA‐based nucleic acid therapy, which eliminates risk of insertional mutagenesis. In addition to these valuable advantages, the mRNA‐based method showed significantly higher efficacy for reprogramming somatic cells to pluripotency compared with DNA‐ or protein‐based methods. These findings suggest cmRNA can provide a powerful and safe tool for cell programming and reprogramming. Delivery methods, particularly using lipid nanoparticles, provide strategies for cell and organ‐specific targeting. The present study comprehensively compares studies that have used cmRNAs for cell fate conversion and tissue engineering. The information should be useful for investigators looking to choose the most efficient and straightforward cmRNA‐based strategy and protocol for tissue engineering and regenerative medicine research. stem cells translational medicine 2019;8:833&843 |
format | Online Article Text |
id | pubmed-6646692 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | John Wiley & Sons, Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-66466922019-07-31 Concise Review: Application of Chemically Modified mRNA in Cell Fate Conversion and Tissue Engineering Badieyan, Zohreh Sadat Evans, Todd Stem Cells Transl Med Tissue Engineering and Regenerative Medicine Chemically modified RNA (cmRNA) has potential as a safe and efficient tool for nucleic acid‐based therapies and regenerative medicine. Modifications in the chemistry of mRNA can enhance stability, reduce immunogenicity, and thus facilitate mRNA‐based nucleic acid therapy, which eliminates risk of insertional mutagenesis. In addition to these valuable advantages, the mRNA‐based method showed significantly higher efficacy for reprogramming somatic cells to pluripotency compared with DNA‐ or protein‐based methods. These findings suggest cmRNA can provide a powerful and safe tool for cell programming and reprogramming. Delivery methods, particularly using lipid nanoparticles, provide strategies for cell and organ‐specific targeting. The present study comprehensively compares studies that have used cmRNAs for cell fate conversion and tissue engineering. The information should be useful for investigators looking to choose the most efficient and straightforward cmRNA‐based strategy and protocol for tissue engineering and regenerative medicine research. stem cells translational medicine 2019;8:833&843 John Wiley & Sons, Inc. 2019-03-19 /pmc/articles/PMC6646692/ /pubmed/30891922 http://dx.doi.org/10.1002/sctm.18-0259 Text en © 2019 The Authors. stem cells translational medicine published by Wiley Periodicals, Inc. on behalf of AlphaMed Press This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Tissue Engineering and Regenerative Medicine Badieyan, Zohreh Sadat Evans, Todd Concise Review: Application of Chemically Modified mRNA in Cell Fate Conversion and Tissue Engineering |
title | Concise Review: Application of Chemically Modified mRNA in Cell Fate Conversion and Tissue Engineering |
title_full | Concise Review: Application of Chemically Modified mRNA in Cell Fate Conversion and Tissue Engineering |
title_fullStr | Concise Review: Application of Chemically Modified mRNA in Cell Fate Conversion and Tissue Engineering |
title_full_unstemmed | Concise Review: Application of Chemically Modified mRNA in Cell Fate Conversion and Tissue Engineering |
title_short | Concise Review: Application of Chemically Modified mRNA in Cell Fate Conversion and Tissue Engineering |
title_sort | concise review: application of chemically modified mrna in cell fate conversion and tissue engineering |
topic | Tissue Engineering and Regenerative Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6646692/ https://www.ncbi.nlm.nih.gov/pubmed/30891922 http://dx.doi.org/10.1002/sctm.18-0259 |
work_keys_str_mv | AT badieyanzohrehsadat concisereviewapplicationofchemicallymodifiedmrnaincellfateconversionandtissueengineering AT evanstodd concisereviewapplicationofchemicallymodifiedmrnaincellfateconversionandtissueengineering |